Vitrolife AB (publ) (STO:VITR)
Sweden · Delayed Price · Currency is SEK 96.30
-1.70 (-1.73%)
Oct 15, 2026, 2:35 PM CET
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 13.04 billion as of October 14, 2026. It is the 8,655th most valuable company in the world and the 113th biggest in Sweden. Its market cap has decreased by 28.88% in one year.
Market Cap
13.04B
Enterprise Value
13.82B
Revenue
3.39B
Global Rank
Country Rank
#113 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 510.85M to 13.04B, an increase of 2,452.84%. That is a compound annual growth rate of 13.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 13.04B | -29.71% |
| Dec 30, 2025 | 18.55B | -36.27% |
| Dec 30, 2024 | 29.11B | 10.43% |
| Dec 29, 2023 | 26.36B | 4.56% |
| Dec 30, 2022 | 25.21B | -66.75% |
| Dec 30, 2021 | 75.82B | 223.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 69.26B |
| Sectra AB | 59.65B |
| Elekta AB | 22.00B |
| Nolato AB | 15.30B |
| MedCap AB | 7.90B |
| Xvivo Perfusion AB | 6.84B |
| CellaVision AB | 3.95B |
| BICO Group AB | 1.76B |